Skip to main content
TipRanks
Go Ultimate75% OFF

Inovio Pharmaceuticals (GBM) Q4 2023 Earnings Report

6 Followers

DE:GBM Q4 2023 EPS Results

Actual EPS
-EUR 1.00
Consensus EPS
-EUR 1.08
Beat/Miss
Beat by +EUR 0.08
One Year Ago EPS
-EUR 2.41

DE:GBM Q4 2023 Revenue Results

Actual Revenue
EUR 93.57K
Expected Revenue
EUR 328.17K
Beat/Miss
Missed by -EUR 234.59K
YoY Revenue Growth
-17.66%

Earnings Announcement Details

Quarter
Q4 2023
Date
03/06/2024
Time
After Close
Conference Call
Wednesday, March 6, 2024
DE:GBM Upcoming Earnings

Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q4 2023 Earnings Call Audio

DE:GBM Q4 2023 Earnings Call
0:00 / 0:00

Q4 2023 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2023 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:GBM Earnings History

DE:GBM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-0.12-0.05――
Nov 10, 20262026 (Q3)-0.19-0.46-0.7942.53% (+0.34)
Aug 12, 20262026 (Q2)-0.20-0.06-0.5688.52% (+0.49)
May 13, 20262026 (Q1)-0.32-0.26-0.4645.10% (+0.21)
Mar 12, 20262025 (Q4)-0.330.05-0.59109.23% (+0.65)
Nov 10, 20252025 (Q3)-0.38-0.79-0.812.25% (+0.02)
Aug 12, 20252025 (Q2)-0.56-0.56-1.0848.74% (+0.53)
May 13, 20252025 (Q1)-0.63-0.46-1.1961.07% (+0.73)
Mar 18, 20252024 (Q4)-0.76-0.59-140.91% (+0.41)
Nov 14, 20242024 (Q3)-1.05-0.81-1.4242.95% (+0.61)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed